Chronic upregulation of the endogenous opioid system impairs the skin flap survival in rats

Annals of Plastic Surgery

Volumn 63, Issue 5, 2009, Pages 558-563

  Nezami, Behtash Ghazi ^a,b   Talab, Saman Shafaat ^a,b   Emami, Hamed ^a,b   Assa, Solmaz ^a,b   Rasouli, Mohammad Reza ^b   Asadi, Shahrzad ^b   Tavangar, Seyed Mohammad ^c   Dehpour, Ahmad Reza ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bile ducts; Cholestasis; Disease models; Ischemia prevention and control; Ligation; Opioid peptides; Rats; Skin; Surgical flaps; Tissue survival

Indexed keywords

NALTREXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP SURVIVAL; UPREGULATION;

ANIMALS; CHOLESTASIS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SURGICAL FLAPS; WOUND HEALING;

EID: 70350633862     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31818d458e     Document Type: Article

References (29)

1. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: A review. Microsurgery. 1993;14:165-175.
2. Granger DN. Ischemia-reperfusion: Mechanism of microvascular dysfunction and the inference of risk factors for cardiovascular disease. Microcirculation. 1999;6:167-173.
3. Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936.
4. Teoh N, Farrell GC. Hepatic ischemia reperfusion injury. Pathogenic mechanisms and basis for protection. J Gastroenterol Hepatol. 2003;18:891-902.
5. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB J. 1990;4:3355-3359.
6. Okajima K, Harada N, Kushimoto S, et al. Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost. 2002;88:473-480. (Pubitemid 35021607)
7. Okada K, Copeland B, Fitridge R, et al. Fibrin contributes to microvascular obstructions and parenchyma changes during early focal cerebral ischemia and reperfusion. Stroke. 1994;25:1847-1854.
8. Konstantakos EK, Dalstrom DJ, Nelles ME, et al. Diagnosis and management of extremity compartment syndromes: An orthopaedic perspective. Am Surg. 2007;73:1199-1209.
9. Soupene S, Kuypers FA. Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol. 2006;133:436-438.
10. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002;62:6132-6140.
11. Rongen GA, Oyen WJ, Ramakers BP, et al. Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation. 2005;111:173-178.
12. Miyanishi M, Tada K, Koike M, et al. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007;450:435-439.
13. Rouhainen A, Imai S, Rauvala H, et al. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost. 2000;84:1087-1094.
14. Kuypers FA, Larkin SK, Emeis JJ, et al. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost. 2007;97:478-486.
15. Teoh NC, Ito Y, Field J, et al. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology. 2007;133:632-646.
16. Shen XD, Ke B, Zhai Y, et al. Diannexin, a novel annexin V homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am J Transplant. 2007;7:2462-2471.
17. Huls M, Kramers C, Levtchenko EN, et al. P-glycoprotein-deficient mice have proximal tubule dysfunction but are protected against ischemic renal injury. Kidney Int. 2007;72:1233-1241.
18. Pohl A, Lage H, Mueller P, et al. Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line. Biochem J. 2002;365:259-268.
19. Zhang X, Hewitt S, Ringold G, et al. Dimerized annexin V accelerates renal functional recovery from ischemic injury. Co-published in Am J Transplant. 2006;6(suppl 2) and Transplantation. 2006;S2(suppl 3). Paper presented at: The World Congress in Transplantation; July 24-27, 2006; Boston, MA.
20. Siemionow M, Nanhekhan LV. Introduction of cremaster muscle chamber technique for long-term intravital microscopy. Ann Plast Surg. 1999;43:161-166.
21. Yazici I, Siemionow M. The grid layer system for mapping of the cremaster muscle flap microcirculation. Plast Reconstr Surg. 2006;117:2112-2113.
22. Sperandio M, Thatte A, Foy D, et al. Severe impairment of leukocyte rolling in venules of core 2 glucosaminyltransferase-deficient mice. Blood. 2001;97: 3812-3819.
23. Van Nieuw Amerongen GP, Draijer R, Vermeer MA, et al. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: Role of protein kinases, calcium and RhoA. Circ Res. 1998;83: 1115-1123.
24. Van Nieuw Amerongen GP, Vermeer MA, Hinsbergh VW. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol. 2000;20:E127-E133.
25. Neidlinger NA, Larkin SK, Bhagat A, et al. Hydrolysis of phosphosphatidylserine exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem. 2006;281:775-781.
26. Maier CM, Hsieh L, Crandall T, et al. Evaluating therapeutic targets for reperfusion- related brain hemorrhage. Ann Neurol. 2006;59:929-938.
27. Rao LV, Tait JF, Hoang HO. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIA/tissue factor activity and prothrombinase activity. Thromb Res. 1992; 67:517-531.
28. Sun J, Bird P, Salem HH. Interaction of annexin V and platelets: Effects on platelet function and protein S binding. Thromb Res. 1993;69:289-294.
29. Reffelman T, Kloner RA. The "no-reflow" phenomenon: Basic science and clinical correlates. Heart. 2002;87:162-168.